Suppr超能文献

田纳西州的医院未遵守 8 项常见实验室检测的价格透明度法规。

Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests.

机构信息

Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, US.

出版信息

Am J Clin Pathol. 2024 Nov 4;162(5):450-454. doi: 10.1093/ajcp/aqae057.

Abstract

OBJECTIVES

The goal of this study was to assess hospital compliance with federal price transparency mandates and barriers to pricing information in Tennessee.

METHODS

All hospitals websites were queried for gross, cash, and BlueCross BlueShield of Tennessee prices for 8 high-frequency laboratory tests in 2 Centers for Medicare & Medicaid Services-mandated pricing sources: (1) a machine-readable file of all available services and (2) a consumer-friendly display of 300 shoppable services. Barriers, including click counts, data availability, and intrahospital price discrepancies, were noted.

RESULTS

Of the 145 Tennessee hospitals assessed, 97.2% were noncompliant with the Centers for Medicare & Medicaid Services final rule. Subanalysis of available machine-readable files, price estimators, and shoppable services files demonstrated 49.6%, 95.1%, and 78.6% noncompliance, respectively. Barriers to pricing information included requiring protected health information (55.9%), missing at least 1 pricing source (7.6%), having no pricing sources available (6.2%), and involving more than 3 clicks to access the cash price in machine-readable files (54.1%) and price estimators (68.6%.) Average intrahospital discrepancy for basic metabolic panel cash prices across pricing sources was $101.30 (range, $0-1012.40).

CONCLUSIONS

Our study showed high levels of noncompliance with price transparency laws, inconsistent and inaccessible pricing, and continued challenges facing patients in Tennessee.

摘要

目的

本研究旨在评估田纳西州医院对联邦价格透明度规定的遵守情况以及定价信息方面存在的障碍。

方法

在 2 个医疗保险和医疗补助服务中心规定的定价来源(1)所有可用服务的机器可读文件和(2)300 种可购物服务的消费者友好型展示中,查询了所有医院网站的 8 项高频实验室检验的总价格、现金价格和田纳西州蓝十字蓝盾价格。注意到障碍,包括点击次数、数据可用性和医院内价格差异。

结果

在所评估的 145 家田纳西州医院中,97.2%不符合医疗保险和医疗补助服务中心的最终规定。对可用的机器可读文件、价格估算器和可购物服务文件的亚组分析分别显示,分别有 49.6%、95.1%和 78.6%不符合规定。定价信息的障碍包括需要保护健康信息(55.9%)、至少缺少 1 个定价来源(7.6%)、没有定价来源可用(6.2%)以及需要超过 3 次点击才能在机器可读文件(54.1%)和价格估算器(68.6%)中访问现金价格。基本代谢面板现金价格在各定价来源之间的平均院内差异为 101.30 美元(范围为 0-1012.40 美元)。

结论

我们的研究表明,田纳西州的医院在价格透明度法规方面存在高度不合规、定价不一致且难以获取的情况,患者仍然面临挑战。

相似文献

1
Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests.
Am J Clin Pathol. 2024 Nov 4;162(5):450-454. doi: 10.1093/ajcp/aqae057.
2
Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.
Clin Orthop Relat Res. 2022 Dec 1;480(12):2316-2326. doi: 10.1097/CORR.0000000000002288. Epub 2022 Jun 24.
4
Evaluation of Hospital Compliance With Federal Price Transparency Regulations and Variability of Negotiated Rates for Spinal Fusion.
J Am Acad Orthop Surg. 2023 Jul 1;31(13):677-686. doi: 10.5435/JAAOS-D-23-00053. Epub 2023 Apr 3.
5
Not Clearing the Air: Hospital Price Transparency for a Laparoscopic Cholecystectomy.
J Surg Res. 2022 Dec;280:501-509. doi: 10.1016/j.jss.2022.07.037. Epub 2022 Sep 5.
7
Investigation of Hospital Pricing Information for Plastic Surgery Procedures Reveals Widespread Violation of the CMS Price Transparency Act.
Plast Reconstr Surg. 2023 Aug 1;152(2):455-462. doi: 10.1097/PRS.0000000000010299. Epub 2023 Feb 15.
9
Health Care Price Transparency in Ophthalmology.
JAMA Ophthalmol. 2021 Nov 1;139(11):1210-1216. doi: 10.1001/jamaophthalmol.2021.3951.
10
Evaluating hospital consumer-friendly price-estimator tools for shoppable services within dermatology.
Arch Dermatol Res. 2023 Aug;315(6):1813-1821. doi: 10.1007/s00403-023-02527-3. Epub 2023 Jan 27.

引用本文的文献

2
Public Awareness and Use of Price Transparency: Report From a National Survey.
Interact J Med Res. 2024 Dec 12;13:e64439. doi: 10.2196/64439.

本文引用的文献

1
The healthcare price transparency illusion: does anyone know what laboratory tests cost?
J Pediatr. 2024 Jan;264:113755. doi: 10.1016/j.jpeds.2023.113755. Epub 2023 Sep 20.
3
United States blood pricing: A cross-sectional analysis of charges and reimbursement at 200 US hospitals.
Am J Hematol. 2023 Jul;98(7):E179-E182. doi: 10.1002/ajh.26940. Epub 2023 Apr 25.
4
Estimating the Impact of New Health Price Transparency Policies.
Inquiry. 2023 Jan-Dec;60:469580231155988. doi: 10.1177/00469580231155988.
5
Price Transparency in Hospitals-Current Research and Future Directions.
JAMA Netw Open. 2023 Jan 3;6(1):e2249588. doi: 10.1001/jamanetworkopen.2022.49588.
9
Large variations in hospital pricing for standard procedures revealed.
BMC Res Notes. 2022 Apr 5;15(1):129. doi: 10.1186/s13104-022-06014-2.
10
Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.
J Gen Intern Med. 2022 Nov;37(14):3577-3584. doi: 10.1007/s11606-021-07237-y. Epub 2021 Dec 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验